Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra F Freeman

Showing results (181-190 of 268) with videos related to

Pageof 27
Sort By:
Nature Medicine|January 22, 2020
Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case reportDoyoung Kim, Tetsuro Kobayashi, Benjamin Voisin, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulationAndrea M Siegel, Kelly D Stone, Glenn Cruse, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2017
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutationsAlexander Vargas-Hernández, Emily M Mace, Ofer Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the LiteratureChrista S Zerbe, Beatriz E Marciano, Rohit K Katial, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2014
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotypeHuie Jing, Qian Zhang, Yu Zhang, et al.
Journal of Human Immunity|January 29, 2026
Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiencyChen Wang, Meera Patel, Amanda Urban, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 5, 2026
Disease-causing STAT3 variants can be discriminated by a functional flow cytometry testAna Esteve-Sole, Alexandra F Freeman, Amy Hsu, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Dedicator of cytokinesis 8-deficient CD4<sup>+</sup> T cells are biased to a T<sub>H</sub>2 effector fate at the expense of T<sub>H</sub>1 and T<sub>H</sub>17 cellsStuart G Tangye, Bethany Pillay, Katrina L Randall, et al.
The Journal of Experimental Medicine|November 26, 2014
DOCK8 regulates lymphocyte shape integrity for skin antiviral immunityQian Zhang, Christopher G Dove, Jyh Liang Hor, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19Reuben McGregor, Daniel Chauss, Tilo Freiwald, et al.
Pageof 27

Showing results (181-190 of 268) with videos related to

Sort By:
Pageof 27
Nature Medicine|January 22, 2020
Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case reportDoyoung Kim, Tetsuro Kobayashi, Benjamin Voisin, et al.
The Journal of Allergy and Clinical Immunology|November 5, 2013
Diminished allergic disease in patients with STAT3 mutations reveals a role for STAT3 signaling in mast cell degranulationAndrea M Siegel, Kelly D Stone, Glenn Cruse, et al.
The Journal of Allergy and Clinical Immunology|November 8, 2017
Ruxolitinib partially reverses functional natural killer cell deficiency in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutationsAlexander Vargas-Hernández, Emily M Mace, Ofer Zimmerman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 9, 2016
Progressive Multifocal Leukoencephalopathy in Primary Immune Deficiencies: Stat1 Gain of Function and Review of the LiteratureChrista S Zerbe, Beatriz E Marciano, Rohit K Katial, et al.
The Journal of Allergy and Clinical Immunology|May 7, 2014
Somatic reversion in dedicator of cytokinesis 8 immunodeficiency modulates disease phenotypeHuie Jing, Qian Zhang, Yu Zhang, et al.
Journal of Human Immunity|January 29, 2026
Extended clinical phenotypes and long-term outcomes of phosphoglucomutase-3 deficiencyChen Wang, Meera Patel, Amanda Urban, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 5, 2026
Disease-causing STAT3 variants can be discriminated by a functional flow cytometry testAna Esteve-Sole, Alexandra F Freeman, Amy Hsu, et al.
The Journal of Allergy and Clinical Immunology|August 25, 2016
Dedicator of cytokinesis 8-deficient CD4<sup>+</sup> T cells are biased to a T<sub>H</sub>2 effector fate at the expense of T<sub>H</sub>1 and T<sub>H</sub>17 cellsStuart G Tangye, Bethany Pillay, Katrina L Randall, et al.
The Journal of Experimental Medicine|November 26, 2014
DOCK8 regulates lymphocyte shape integrity for skin antiviral immunityQian Zhang, Christopher G Dove, Jyh Liang Hor, et al.
Biorxiv : the Preprint Server for Biology|August 4, 2020
An autocrine Vitamin D-driven Th1 shutdown program can be exploited for COVID-19Reuben McGregor, Daniel Chauss, Tilo Freiwald, et al.
Pageof 27